These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18206248)

  • 1. A two-factor structure for the Schedule for the Deficit Syndrome in schizophrenia.
    Nakaya M; Ohmori K
    Psychiatry Res; 2008 Mar; 158(2):256-9. PubMed ID: 18206248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reexamination of the characteristics of the deficit schizophrenia patients.
    Tiryaki A; Yazici MK; Anil AE; Kabakçi E; Karaağaoğlu E; Göğüş A
    Eur Arch Psychiatry Clin Neurosci; 2003 Oct; 253(5):221-7. PubMed ID: 14504990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting domain-specific insight of schizophrenia patients from symptomatology, multiple neurocognitive functions, and personality related traits.
    Ritsner MS; Blumenkrantz H
    Psychiatry Res; 2007 Jan; 149(1-3):59-69. PubMed ID: 17137634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attribution biases in schizophrenia: relationship to clinical and functional impairments.
    Cohen AS; Nienow TM; Dinzeo TJ; Docherty NM
    Psychopathology; 2009; 42(1):40-6. PubMed ID: 19023233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of cognitive from affective components of theory of mind in schizophrenia.
    Shamay-Tsoory SG; Shur S; Barcai-Goodman L; Medlovich S; Harari H; Levkovitz Y
    Psychiatry Res; 2007 Jan; 149(1-3):11-23. PubMed ID: 17107716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emotional information processing in violent patients with schizophrenia: association with psychopathy and symptomatology.
    Fullam R; Dolan M
    Psychiatry Res; 2006 Jan; 141(1):29-37. PubMed ID: 16343643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kraepelinian subtype and deficit syndrome in chronic schizophrenia.
    Nakaya M; Ohmori K
    Psychiatry Res; 2006 Nov; 144(2-3):221-5. PubMed ID: 16962177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thought Disorder Index: a longitudinal study of severity levels and schizophrenia factors.
    Metsänen M; Wahlberg KE; Hakko H; Saarento O; Tienari P
    J Psychiatr Res; 2006 Apr; 40(3):258-66. PubMed ID: 15907939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor analysis of the catatonia rating scale and catatonic symptom distribution across four diagnostic groups.
    Krüger S; Bagby RM; Höffler J; Bräunig P
    Compr Psychiatry; 2003; 44(6):472-82. PubMed ID: 14610726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The initial prodrome of schizophrenia: different duration, different underlying deficits?
    Schultze-Lutter F; Ruhrmann S; Hoyer C; Klosterkötter J; Leweke FM
    Compr Psychiatry; 2007; 48(5):479-88. PubMed ID: 17707258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familiality in a five-factor model of schizophrenia psychopathology: findings from a 16-month follow-up study.
    Ritsner M; Ratner Y; Gibel A; Weizman R
    Psychiatry Res; 2005 Sep; 136(2-3):173-9. PubMed ID: 16098602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two new scales of formal thought disorder in schizophrenia.
    Barrera A; McKenna PJ; Berrios GE
    Psychiatry Res; 2008 Jan; 157(1-3):225-34. PubMed ID: 17997165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations of attitudes toward antipsychotic drugs with insight and objective psychopathology in schizophrenia.
    Rocca P; Crivelli B; Marino F; Mongini T; Portaleone F; Bogetto F
    Compr Psychiatry; 2008; 49(2):170-6. PubMed ID: 18243890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia.
    Fan X; Henderson DC; Nguyen DD; Cather C; Freudenreich O; Evins AE; Borba CP; Goff DC
    Psychiatry Res; 2008 May; 159(1-2):140-6. PubMed ID: 18423611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure of the Autism Diagnostic Interview-Revised: diagnostic and phenotypic implications.
    Snow AV; Lecavalier L; Houts C
    J Child Psychol Psychiatry; 2009 Jun; 50(6):734-42. PubMed ID: 19207624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Barcelona Test for cognitive assessment of patients with schizophrenia.
    Gil D; Bengochea R; Arrieta M; Lastra I; Sánchez R; Alvarez A; Diego M; Prat R
    Actas Esp Psiquiatr; 2008; 36(6):337-44. PubMed ID: 18781409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A taxometric analysis of schizophrenia symptoms.
    Cuesta MJ; Ugarte MD; Goicoa T; Eraso S; Peralta V
    Psychiatry Res; 2007 Apr; 150(3):245-53. PubMed ID: 17316823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopathology in never-treated schizophrenia.
    Tirupati SN; Padmavati R; Thara R; McCreadie RG
    Compr Psychiatry; 2006; 47(1):1-6. PubMed ID: 16324896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.